Concepedia
Gene Therapy · 2008 · 26 citations · 32 references
PharmacyOncologyPharmacokineticsCancer PharmacologyPharmacokinetics Of Anticancer AgentsTumor MicroenvironmentCancer Drug DeliveryOncogenic VirusesOncolytic Virus TherapyViral EntryViral ReleaseVirus EntryAdenoviral VectorsAdenovirus VectorsDirect Injection
32
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
Steven E. Raper, Narendra Chirmule, Frank S. Lee et al. · Molecular Genetics and Metabolism · 2003 · 1.5K citations
Life Sciences, Immunology, Molecular Genetics +14
Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer
John Nemunaitis, Fadlo R. Khuri, Ian Ganly et al. · Journal of Clinical Oncology · 2001 · 474 citations · Full text
Life Sciences, Immunology, Oncology +17
The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors
André Lieber, C Y He, Leonard Meuse et al. · Journal of Virology · 1997 · 414 citations · Full text
Life Sciences, Immunology, Pathobiology +17
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.
Theodore L. DeWeese, H. Van der Poel, S. Li et al. · PubMed · 2001 · 386 citations
Medicine, Oncology, Radiation Oncology +16
A Pilot Study of <i>In Vivo</i> Liver-Directed Gene Transfer with an Adenoviral Vector in Partial Ornithine Transcarbamylase Deficiency
Steven E. Raper, Marc Yudkoff, Narendra Chirmule et al. · Human Gene Therapy · 2002 · 350 citations
Life Sciences, Molecular Biology, Molecular Genetics +17